» Articles » PMID: 15767573

Extremely Potent Triterpenoid Inducers of the Phase 2 Response: Correlations of Protection Against Oxidant and Inflammatory Stress

Abstract

A series of synthetic triterpenoid (TP) analogues of oleanolic acid are powerful inhibitors of cellular inflammatory processes such as the induction by IFN-gamma of inducible nitric oxide synthase (iNOS) and of cyclooxygenase 2 in mouse macrophages. Here, we show that these analogues are also extremely potent inducers of the phase 2 response [e.g., elevation of NAD(P)H-quinone oxidoreductase and heme oxygenase 1], which is a major protector of cells against oxidative and electrophile stress. Moreover, like previously identified phase 2 inducers, the TP analogues use the antioxidant response element-Nrf2-Keap1 signaling pathway. Thus, induction of the phase 2 response and suppression of the iNOS induction was abrogated in nrf2(-/-) and keap1(-/-) mouse embryonic fibroblasts. The high potency of TP analogues in inducing the phase 2 response and blocking inflammation depends on the presence of activated Michael reaction (enone) functions at critical positions in rings A and C. The most potent TP doubles NAD(P)H-quinone oxidoreductase in murine hepatoma cells at 0.28 nM and has an IC(50) for suppression of iNOS induction in primary mouse macrophages of 0.0035 nM. The direct interaction of this TP with thiol groups of the Keap1 sensor for inducers is demonstrated spectroscopically. The antiinflammatory and phase 2 inducer potencies of 18 TP are closely linearly correlated (r(2) = 0.91) over 6 orders of magnitude of concentration. Thus, in addition to blocking inflammation and promoting differentiation, these TP exhibit another very important protective property: the induction of the phase 2 response.

Citing Articles

Mitochondrial diseases: from molecular mechanisms to therapeutic advances.

Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.

PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.


New Synthetic Analogs of Natural 5Z,9Z-Dienoic Acids-Hybrid Molecules Based on Oleanolic Acid: Synthesis and Study of Antitumor Activity.

Tuktarova R, Dzhemileva L, Dzhemilev U, Dyakonov V Cancers (Basel). 2024; 16(23).

PMID: 39682082 PMC: 11640419. DOI: 10.3390/cancers16233893.


Therapeutic effects of Huangqi formula (Eefooton) in chronic kidney disease: clinical research and narrative literature review.

Lu K, Wu S, Lu T, Tzeng I, Kuo C, Hung Y Aging (Albany NY). 2024; 16(22):13627-13647.

PMID: 39652245 PMC: 11723655. DOI: 10.18632/aging.206170.


Covalent Inhibitors of KEAP1 with Exquisite Selectivity.

Fejes I, Markacz P, Tatai J, Rudas M, Dunkel P, Gyuris M J Med Chem. 2024; 67(23):21208-21222.

PMID: 39572012 PMC: 11647895. DOI: 10.1021/acs.jmedchem.4c02019.


Delineating cysteine-reactive compound modulation of cellular proteostasis processes.

Julio A, Shikwana F, Truong C, Burton N, Dominguez 3rd E, Turmon A Nat Chem Biol. 2024; .

PMID: 39448844 DOI: 10.1038/s41589-024-01760-9.


References
1.
Honda T, Gribble G, Suh N, Finlay H, Rounds B, Bore L . Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. J Med Chem. 2000; 43(9):1866-77. DOI: 10.1021/jm000008j. View

2.
Prestera T, Talalay P, Alam J, Ahn Y, Lee P, Choi A . Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med. 1995; 1(7):827-37. PMC: 2230011. View

3.
Dinkova-Kostova A, Massiah M, Bozak R, Hicks R, Talalay P . Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci U S A. 2001; 98(6):3404-9. PMC: 30666. DOI: 10.1073/pnas.051632198. View

4.
Juurlink B . Therapeutic potential of dietary phase 2 enzyme inducers in ameliorating diseases that have an underlying inflammatory component. Can J Physiol Pharmacol. 2001; 79(3):266-82. View

5.
Ito Y, Pandey P, Sporn M, Datta R, Kharbanda S, Kufe D . The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol Pharmacol. 2001; 59(5):1094-9. DOI: 10.1124/mol.59.5.1094. View